JPS62155204A - Skin external preparation - Google Patents
Skin external preparationInfo
- Publication number
- JPS62155204A JPS62155204A JP29664785A JP29664785A JPS62155204A JP S62155204 A JPS62155204 A JP S62155204A JP 29664785 A JP29664785 A JP 29664785A JP 29664785 A JP29664785 A JP 29664785A JP S62155204 A JPS62155204 A JP S62155204A
- Authority
- JP
- Japan
- Prior art keywords
- external preparation
- skin external
- skin
- ascorbigen
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/606—Nucleosides; Nucleotides; Nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は肌荒れを改善し、皮膚に潤いと艶を与える効果
に優れた皮膚外用剤に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a skin preparation for external use that is excellent in improving rough skin and imparting moisture and luster to the skin.
[従来の技術]
化粧料等の皮膚外用剤の大きな目的の一つに肌荒れ防止
、改善がある。この目的を達成するために従来は各種保
湿剤を配合することが行なわれてきた。[Prior Art] One of the major purposes of external skin preparations such as cosmetics is to prevent and improve skin roughness. In order to achieve this objective, various moisturizing agents have conventionally been added.
〔発明が解決しようとする問題点]
しかしながら保湿剤例えば多価アルコールやコンドロイ
チン硫酸などは多量に配合するとべたついたり、はてり
感がでたりする欠点を有していた。[Problems to be Solved by the Invention] However, moisturizing agents such as polyhydric alcohols and chondroitin sulfate have the disadvantage that when incorporated in large amounts, they become sticky or give a sticky feeling.
[問題点を解決するための手段]
本発明者等は、このような事情に鑑み、肌荒れ改善効果
に優れた皮膚外用剤を得るべく鋭意研究を重ねた結果、
アスコルビゲンを皮膚外用剤に配合することにより肌荒
れ改善効果に優れた皮膚外用剤が得られることを見出し
、本発明を完成するに至った。[Means for Solving the Problems] In view of the above circumstances, the present inventors have conducted extensive research to obtain a skin external preparation with excellent effects on improving rough skin.
The present inventors have discovered that by incorporating ascorbigen into an external skin preparation, a skin preparation with excellent effects on improving rough skin can be obtained, and the present invention has been completed.
すなわち、本発明は、アスコルビゲンを含有することを
特徴とする皮膚外用剤である。That is, the present invention is a skin external preparation characterized by containing ascorbigen.
以下、本発明の構成について詳述する。Hereinafter, the configuration of the present invention will be explained in detail.
本発明に用いられるアスコルビゲンには立体配置の違い
によりアスコルビゲンAとアスコルビゲンBとがあり、
それぞれ下式(a)または(b)で表される化合物であ
る。Ascorbigen used in the present invention includes ascorbigen A and ascorbigen B due to differences in steric configuration.
These are compounds represented by the following formulas (a) or (b), respectively.
いずれも無定形の粉末でエタノール可溶性である。本発
明の皮膚外用剤にはこれらのいずれを用いても良くまた
混合物であっても良い。Both are amorphous powders and soluble in ethanol. Any of these may be used in the skin external preparation of the present invention, or a mixture thereof may be used.
配合量は皮膚外用全景中の0.001〜30重量%が好
ましく、ざらに好ましくは0.01〜20重量%である
。0.001%未満では本発明の効果を発揮しにくり3
0%を超えて配合しても効果の増大は期待できない。The blending amount is preferably 0.001 to 30% by weight, more preferably 0.01 to 20% by weight based on the total skin appearance. If it is less than 0.001%, the effect of the present invention cannot be exhibited.3
Even if it is added in excess of 0%, no increase in effect can be expected.
本発明の皮膚外用剤は化粧料、医薬品、医薬部外品等外
皮に適用されるものを指し、従ってその剤型も水溶液系
、可溶化系、乳化系、粉末系、油液系、ゲル系、軟膏系
、水−油2層系、水−油一粉末3層系等幅広い形態を取
り得る。The skin external preparations of the present invention refer to those applied to the skin, such as cosmetics, pharmaceuticals, and quasi-drugs, and therefore, the dosage forms include aqueous solutions, solubilized systems, emulsified systems, powder systems, oil liquid systems, and gel systems. It can take a wide range of forms, such as an ointment system, a water-oil two-layer system, and a water-oil-powder three-layer system.
本発明の皮膚外用剤には上記した必須成分の他に通常化
粧品や医薬品等の皮膚外用剤に用いられる他の成分、例
えば油分、湿潤剤、紫外線吸収剤、酸化防止剤、界面活
性剤、防腐剤、保湿剤、薬剤、香料、水、アルコール、
増粘剤、色剤等を必要に応じて適宜配合することができ
る。In addition to the above-mentioned essential ingredients, the external skin preparation of the present invention contains other ingredients normally used in external skin preparations such as cosmetics and pharmaceuticals, such as oil, humectants, ultraviolet absorbers, antioxidants, surfactants, and preservatives. agents, moisturizers, drugs, fragrances, water, alcohol,
Thickeners, coloring agents, etc. can be added as appropriate.
次に実施例をあげて本発明をさらに詳細に説明する。本
発明はこれにより限定されるものではない。配合量は重
量%である。Next, the present invention will be explained in more detail with reference to Examples. The present invention is not limited thereby. The blending amount is in weight%.
実施例に先立ち効果試験法について述べる。Prior to working examples, the effectiveness testing method will be described.
芒れ 芒れ己差 舌
女性健康人(顔面)の皮膚表面形態をミリスチン樹脂に
よるレプリカ法を用いて肌のレプリカを採り顕微鏡(1
7倍)にて観察した。すなわち皮紋の状態および角層の
剥離状態から表1に示す基準に基づいて肌荒れ評価1.
2と判断された者(肌荒れパネル)30名を用い、顔面
左右半々に、実施例1、比較例1のクリームを1日2回
塗布した。2週間後再びレプリカを採り肌の状態を観察
し、前記同様表1に示す基準に従って評価し表1
判定は該評点をもとに下記の基準で行なった。Awn Difference in awn Tongue A replica of the skin surface of a healthy female person (face) was taken using a replica method using myristic resin and examined under a microscope (1
Observation was made at 7x magnification. That is, the skin roughness was evaluated as 1. based on the criteria shown in Table 1 based on the condition of the skin pattern and the peeling condition of the stratum corneum.
The creams of Example 1 and Comparative Example 1 were applied twice a day to the left and right half of the face of 30 people who were judged to have skin irritation of 2 (rough skin panel). Two weeks later, a replica was taken again and the condition of the skin was observed and evaluated according to the criteria shown in Table 1 in the same manner as above.
O:評点4及び5と評価されたパネルの割合が75%以
上
△:評点4及び5と評価されたパネルの割合が25%以
上75%未満
×:評点4及び5と評価されたパネルの割合が25%未
満
実施例1および2
表2の配合組成よりなるローションを常法により製造し
た。O: The proportion of panels rated 4 and 5 is 75% or more △: The proportion of panels rated 4 and 5 is 25% or more and less than 75% ×: The proportion of panels rated 4 and 5 is less than 25% Examples 1 and 2 Lotions having the formulation shown in Table 2 were manufactured by a conventional method.
表2
(以下余白)
表2から明らかなように、本発明の皮膚外用剤は肌荒れ
改善効果に優れた新規な皮膚外用剤である。Table 2 (blank below) As is clear from Table 2, the skin external preparation of the present invention is a novel skin external preparation with excellent effects on improving rough skin.
実施例3 乳液 次の処方に従い、常法により乳液を製造した。Example 3 Emulsion A milky lotion was produced by a conventional method according to the following recipe.
ステアリン酸 2.0セタ
ノール 1.0ワセリン
3.0ラノリンアル
コール 2.0流動パラフイン
8.0スクワラン
3.0エス力ロール507
2.0アスコルビゲン
0.001POE (10)モノオレ
ート 2.5トリエタノールアミ
ン 1.0プロピレングリコール
5.0防腐剤
適量香料
適量蒸留水 残余
実施例4 栄養クリーム
次の処方に従い、常法により栄養クリームを製造した。Stearic acid 2.0 Cetanol 1.0 Vaseline 3.0 Lanolin alcohol 2.0 Liquid paraffin
8.0 Squalane
3.0 S force roll 507
2.0 Ascorbigen
0.001POE (10) Monooleate 2.5 Triethanolamine 1.0 Propylene glycol
5.0 preservative
Appropriate amount of fragrance
Appropriate amount of distilled water Remaining Example 4 Nutritional Cream A nutritional cream was produced by a conventional method according to the following recipe.
ステアリン酸 2・0ステ
アリルアルコール 7.0還元ラノ
リン 2.0スクワラン
5・Oオクチルドテカノ
ール 6.0POE (25)セチル
エーテル 3.0グリセリルモノステ
アレート 2.0防腐剤
適量香料
適量プロピレングリコール
5.0アスコルビゲン 0.
05蒸留水 残余実施
例5 パック
次の処方に従い、常法によりバックを製造した。Stearic acid 2.0 Stearyl alcohol 7.0 Reduced lanolin 2.0 Squalane
5.0 Octyldotecanol 6.0 POE (25) Cetyl ether 3.0 Glyceryl monostearate 2.0 Preservative
Appropriate amount of fragrance
Appropriate amount of propylene glycol
5.0 Ascorbigen 0.
05 Distilled water Remaining Example 5 Pack A bag was manufactured by a conventional method according to the following recipe.
カオリン 65.0タル
ク 19.Oプロピレ
ングリコール 5.0酢酸カルシウ
ム 0.01尿素
0.5アスコルビゲン
3.0香料
0.39実施例6 リップトリートメ
ント
常法に従って以下の処方のリップトリートメントを製造
した。Kaolin 65.0 Talc 19. O Propylene glycol 5.0 Calcium acetate 0.01 Urea
0.5 Ascorbigen
3.0 fragrance
0.39 Example 6 Lip Treatment A lip treatment having the following formulation was manufactured according to a conventional method.
キャンデリラロウ 9.0固形
パラフイン 8.0ミツロウ
5.0カルナバロウ
5.0ラノリン
11.0ヒマシ油
残余アスコルピゲン
5.0イソプロピルミリステート
10.0香料
適量酸化防止剤 適量実
施例3〜dの皮膚外用剤は、肌荒れ改善効果に優れた皮
膚外用剤であった。Candelilla wax 9.0 Solid paraffin 8.0 Beeswax
5.0 carnauba wax
5.0 lanolin
11.0 Castor oil
residual ascorpigen
5.0 isopropyl myristate
10.0 fragrance
Appropriate amount of antioxidant Appropriate amount The skin preparations for external use of Examples 3 to d were excellent skin preparations for improving rough skin.
Claims (1)
外用剤。(1) A skin external preparation characterized by containing ascorbigen.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP29664785A JPS62155204A (en) | 1985-12-27 | 1985-12-27 | Skin external preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP29664785A JPS62155204A (en) | 1985-12-27 | 1985-12-27 | Skin external preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS62155204A true JPS62155204A (en) | 1987-07-10 |
Family
ID=17836245
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP29664785A Pending JPS62155204A (en) | 1985-12-27 | 1985-12-27 | Skin external preparation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS62155204A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2913422A1 (en) * | 2007-03-09 | 2008-09-12 | Oreal | Depigmenting, lightening and/or bleaching keratinous materials comprises applying a cosmetic composition comprising furofuran compounds or its salts and optical isomers |
-
1985
- 1985-12-27 JP JP29664785A patent/JPS62155204A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2913422A1 (en) * | 2007-03-09 | 2008-09-12 | Oreal | Depigmenting, lightening and/or bleaching keratinous materials comprises applying a cosmetic composition comprising furofuran compounds or its salts and optical isomers |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0780116B1 (en) | External skin preparation | |
AU670448B2 (en) | Cosmetic composition in the form of a water/oil/water triple emulsion with gelled external phase | |
JP4252899B2 (en) | Topically applied composition containing multivesicular emulsion and method for producing the same | |
JP3483988B2 (en) | Skin preparation | |
JP2003095915A (en) | Skin care composition | |
US5753242A (en) | External skin treatment composition | |
JP4518367B2 (en) | Pore reducing agent | |
JP2001081008A (en) | Skin preparation for external use keeping and improving the skin from chapping | |
JPH11130652A (en) | Skin cosmetic | |
JPS625909A (en) | Preventing agent for skin elastosis | |
JPH07215838A (en) | Skin external agent | |
JPH0687730A (en) | Cosmetic | |
JPH07215839A (en) | Skin external agent | |
JPS62155204A (en) | Skin external preparation | |
KR101322850B1 (en) | The cosmetic composition for pore-minimizing and inhibition of Sebum Secretion containing the extract of leaves of Mentha arvensis var. piperascens, wheat bud, and Platycodon grandiflorum | |
JPH07138125A (en) | Dermal agent for external use | |
JP3001121B2 (en) | External preparation for skin | |
JPH07215832A (en) | Skin external preparation | |
JP2522803B2 (en) | Cosmetics | |
JPH08268866A (en) | Dermal preparation for external use | |
JP2720247B2 (en) | External preparation for skin | |
JPH0415763B2 (en) | ||
JPH03279310A (en) | External preparation of skin | |
JP2000256168A (en) | Skin lotion | |
JPH115725A (en) | Preparation for external use for skin |